Revisión por temas de las publicaciones en las que han participado miembros del grupo durante el primer semestre del año

Archivado en Noticias

Estudios sobre colitis ulcerosa

1. Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments.

Barreiro-Alonso E, Saro-Gismera C, Sánchez M.
Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):733-741. doi: 10.1080/17474124.2018.1489231. Epub 2018 Jun 27.
PMID: 29911903

2. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care- an Evidence-Based Guideline from ECCO and ESPGHAN.
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK.
J Pediatr Gastroenterol Nutr. 2018 May 30. doi: 10.1097/MPG.0000000000002035. [Epub ahead of print]
PMID: 29851766

3. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis; An Evidence-based Consensus Guideline from ECCO and ESPGHAN.
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK.
J Pediatr Gastroenterol Nutr. 2018 May 30. doi: 10.1097/MPG.0000000000002036. [Epub ahead of print]
PMID: 29851767

4. Using Vedolizumab to treat Severe Sweet’s Syndrome in a Patient with Ulcerative Colitis.
Belvis Jiménez M, Maldonado Pérez B, Argüelles-Arias F.
J Crohns Colitis. 2018 May 19. doi: 10.1093/ecco-jcc/jjy066. [Epub ahead of print] No abstract available.
PMID: 29788419

5. Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors.
Muñoz-Villafranca C, Ortiz de Zarate J, Arreba P, Higuera R, Gómez L, Ibáñez S, Merino O, Muñagorri A, Ogueta M, Rodriguez C, Nantes O, Ramirez de la Piscina P, Rodríguez I, Bernal A, Arévalo J, Cabriada J.
Dig Liver Dis. 2018 Mar 14. pii: S1590-8658(18)30225-1. doi: 10.1016/j.dld.2018.03.007. [Epub ahead of print]
PMID: 29625907

6. Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).
Marín-Jiménez I, Saro C, Díaz V, Acosta MB, Gómez-García M, Casbas AG.
Drugs Context. 2018 Mar 6;7:212505. doi: 10.7573/dic.212505. eCollection 2018.
PMID: 29535792

7. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
Fernández-Blanco JI, Fernández-Díaz G, Cara C, Vera MI, Olivares D, Taxonera C.
Dig Dis Sci. 2018 Mar;63(3):731-737. doi: 10.1007/s10620-018-4935-5. Epub 2018 Jan 25.
PMID: 29372480

Estudios sobre MEIs asociadas

1. Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease.
Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J. Biomed Res Int. 2018 May 8;2018:8618703. doi: 10.1155/2018/8618703. eCollection 2018.
PMID: 29854801

Estudios sobre inmunológia y EII

1. The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation.
Montalban-Arques A, Chaparro M, Gisbert JP, Bernardo D.
Inflamm Bowel Dis. 2018 May 18. doi: 10.1093/ibd/izy177. [Epub ahead of print]
PMID: 29788271

2. Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease.
Bernardo D, Marin AC, Fernández-Tomé S, Montalban-Arques A, Carrasco A, Tristán E, Ortega-Moreno L, Mora-Gutiérrez I, Díaz-Guerra A, Caminero-Fernández R, Miranda P, Casals F, Caldas M, Jiménez M, Casabona S, De la Morena F, Esteve M, Santander C, Chaparro M, Gisbert JP.
Mucosal Immunol. 2018 May 9. doi: 10.1038/s41385-018-0030-7. [Epub ahead of print]
PMID: 29743615

3. Alpha-defensins (α-Defs) in Crohn’s disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.
Cerrillo E, Moret I, Iborra M, Ramos D, Busó E, Tortosa L, Sáez-González E, Nos P, Beltrán B.
Clin Exp Immunol. 2018 Apr;192(1):120-128. doi: 10.1111/cei.13085. Epub 2018 Jan 10.
PMID: 29193023

Estudios sobre prevención, seguridad y profilaxis

1. Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?
Cabriada JL, Ruiz-Zorrilla R, Barrio J, Atienza R, Huerta A, Rodríguez-Lago I, Bernal A, Herrero C.
Turk J Gastroenterol. 2018 May;29(3):292-298. doi: 10.5152/tjg.2018.17162.
PMID: 29755013
2. Prevalence and risk factors for colorectal adenomas in patients with ulcerative colitis.
Gordillo J, Zabana Y, Garcia-Planella E, Mañosa M, Llaó J, Gich I, Marín L, Szafranska J, Sáinz S, Bessa X, Cabré E, Domènech E.
United European Gastroenterol J. 2018 Mar;6(2):322-330. doi: 10.1177/2050640617718720. Epub 2017 Jun 22.
PMID: 29511562
3. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, Magro F, Avni Biron I, Lopez-Serrano P, Casanova MJ, Gompertz M, Vitor S, Arroyo M, Pugliese D, Zabana Y, Vicente R, Aguas M, Bar-Gil Shitrit A, Gutierrez A, Doherty GA, Fernandez-Salazar L, Martínez Cadilla J, Huguet JM, O’Toole A, Stasi E, Manceñido Marcos N, Villoria A, Karmiris K, Rahier JF, Rodriguez C, Diz-Lois Palomares M, Fiorino G, Benitez JM, Principi M, Naftali T, Taxonera C, Mantzaris G, Sebkova L, Iade B, Lissner D, Ferrer Bradley I, Lopez-San Roman A, Marin-Jimenez I, Merino O, Sierra M, Van Domselaar M, Caprioli F, Guerra I, Peixe P, Piqueras M, Rodriguez-Lago I, Ber Y, van Hoeve K, Torres P, Gravito-Soares M, Rudbeck-Resdal D, Bartolo O, Peixoto A, Martin G, Armuzzi A, Garre A, Donday MG, Martín de Carpi FJ, Gisbert JP.
Am J Gastroenterol. 2018 Mar;113(3):396-403. doi: 10.1038/ajg.2017.501. Epub 2018 Feb 20

Revisiones sistemáticas

1. Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
Gisbert JP, Chaparro M.
Gastroenterol Hepatol. 2018 Jun – Jul;41(6):389-405. doi: 10.1016/j.gastrohep.2018.04.005. Epub 2018 May 9. English, Spanish.

Granulocitoaferesis

1. Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view.
Rodríguez-Lago I, Benítez JM, García-Sánchez V, Gutiérrez A, Sempere L, Ginard D, Barreiro-de Acosta M, Cabriada JL.
Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110-9. doi: 10.1016/j.gastrohep.2018.04.007. [Epub ahead of print] English, Spanish.
PMID: 29739692

2. Combination therapy with cytapheresis plus vedolizumab in a corticosteroid-dependent patient with ulcerative colitis and previous ANTI-TNF-α drug failure.
Sáez-González E, Aguas M, Huguet JM, Nos P, Beltrán B.
Dig Liver Dis. 2018 Apr;50(4):415-417. doi: 10.1016/j.dld.2018.01.124. Epub 2018 Feb 1. No abstract available.

Estudios sobre técnicas endoscópicas y radiológicas y EII

1. Comparison of Capsule Endoscopy and Magnetic Resonance Enterography for the Assessment of Small Bowel Lesions in Crohn’s Disease.
González-Suárez B, Rodriguez S, Ricart E, Ordás I, Rimola J, Díaz-González Á, Romero C, de Miguel CR, Jáuregui A, Araujo IK, Ramirez A, Gallego M, Fernández-Esparrach G, Ginés Á, Sendino O, Llach J, Panés J.
Inflamm Bowel Dis. 2018 Mar 19;24(4):775-780. doi: 10.1093/ibd/izx107.
PMID: 29506048

2. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
Jusué V, Chaparro M, Gisbert JP.
Dig Liver Dis. 2018 Apr;50(4):353-359. doi: 10.1016/j.dld.2017.12.022. Epub 2017 Dec 30.
PMID: 29396129

3. Role of magnetic resonance imaging in the management of perianal Crohn’s disease.
Gallego JC, Echarri A.
Insights Imaging. 2018 Feb;9(1):47-58. doi: 10.1007/s13244-017-0579-9. Epub 2017 Nov 15. Review.
PMID: 29143190

archivado en Noticias | publicado el 6 de julio de 2018 | última actualización: 6 de julio de 2018 12:57
Formación EII
Canal de GETECCU en YouTube
Base de datos ENEIDA
Nuestros patrocinadores|lea nuestra política de patrocinio